Revamping the United States Organ Donation System: An Ethical Justification for Compensated Live Organ Donation
[Thesis]
Jordan G. Potter
Magill, Gerard
Duquesne University
2017
304
Committee members: Gielen, Joris; ten Have, Henk
Place of publication: United States, Ann Arbor; ISBN=978-1-369-76971-5
Ph.D.
Health Care Ethics
Duquesne University
2017
With over 100,000 Americans currently on organ waiting lists in the United States, the mass shortage of viable organs for transplantation is one of the most pressing healthcare issues that we face as a country today. Thousands of these individuals on organ waiting lists will ultimately die waiting on an organ transplant that will never come. Many differing proposals have been discussed with the aim of increasing organ donation rates and the raw number of organs available for transplant, including changing our default consent status for cadaveric organ donation and the option of incentivizing organ donation by compensating live donors with financial incentives. Iran is the only nation in the world that currently has a legally regulated system of compensated live organ donation (CLOD), specifically for kidneys, and it has been successful since its implementation, even eradicating its kidney waiting list, which no other nation in the world can claim. However, even with this practical success, CLOD has been a very controversial concept in the professional bioethics literature, and it has been labeled as unethical and illegal in many Western countries, including the United States.
Ethics; Philosophy; Health sciences; Political science
Philosophy, religion and theology;Social sciences;Health and environmental sciences;Commodification;Compensated organ donation;Exploitation;Organ donation;Organ sales;Trafficking